MigraineMind research summary
Real-world effectiveness and safety of eptinezumab in migraine prevention.
Expert Opin Biol Ther | 2026
Clinical trialSummary
Eptinezumab is a new medication for preventing migraines. It is an intravenous treatment that targets a specific protein involved in migraine attacks. Previous studies showed it works well for both episodic and chronic migraines. However, these studies often included strict patient criteria. This makes it hard to apply the findings to everyday patients. This review looks at how effective and safe eptinezumab is in real-world settings. It focuses on patients who have not responded to other treatments, those who overuse medications, and patients with heart issues. Real-world results show that eptinezumab can provide quick relief for a wider range of patients. Most side effects are mild and temporary, but some patients may experience allergic reactions during the infusion. Overall, while the results are promising, they may not fully represent the entire patient population. Clinical relevance: This research highlights that eptinezumab may benefit a broader range of migraine patients, including those who previously struggled with other treatments.
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.
